ArticleThe Journal of small animal practice2026
Electrophoretic patterns of proteinuria in dogs with Cushing's syndrome.
Article in The Journal of small animal practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effect of trilostane treatment on proteinuria secondary to spontaneous hypercortisolism in dogs.Journal of veterinary internal medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesTo describe the electrophoretic pattern of proteinuria in dogs with naturally occurring Cushing's syndrome. We hypothesised that urine protein electrophoresis in dogs with spontaneous Cushing's syndrome will reveal glomerular proteinuria. We also hypothesised that the severity of proteinuria would decrease during treatment with trilostane. MATERIALS AND
methodsThis prospective study included dogs with spontaneous Cushing's syndrome (n = 19) and healthy dogs (n = 10) serving as controls for urine protein electrophoresis. Urinary proteins were evaluated using sodium dodecyl sulphate agarose gel electrophoresis.
resultsThirteen dogs with Cushing's syndrome had glomerular proteinuria, with high molecular weight bands between 66 and 150 kDa. Three dogs with Cushing's syndrome had mixed glomerular and tubular proteinuria, with low molecular weight bands between 14.3 and 26 kDa, in addition to high molecular weight bands. Three dogs with Cushing's syndrome had a physiological pattern of urine protein electrophoresis and these dogs were non-proteinuric. Seven dogs were re-evaluated 4 to 6 months after initiating treatment with trilostane. Before treatment, six dogs were proteinuric and one dog was non-proteinuric. After the treatment, three dogs were non-proteinuric and four dogs were proteinuric. Of these, proteinuria decreased in one dog (50%) and increased (up to 70%) in three dogs. CLINICAL SIGNIFICANCE: Dogs with Cushing's syndrome predominantly exhibit glomerular proteinuria. No systematic improvement was observed during trilostane treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.